BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 23618949)

  • 1. The use of hypoxic cultured mesenchymal stem cell for oncolytic virus therapy.
    Huang YF; Chen MJ; Wu MH; Hung SC
    Cancer Gene Ther; 2013 May; 20(5):308-16. PubMed ID: 23618949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stromal cells for the delivery of oncolytic viruses in gliomas.
    Parker Kerrigan BC; Shimizu Y; Andreeff M; Lang FF
    Cytotherapy; 2017 Apr; 19(4):445-457. PubMed ID: 28233640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.
    Hu ZB; Wu CT; Wang H; Zhang QW; Wang L; Wang RL; Lu ZZ; Wang LS
    Cancer Gene Ther; 2008 Mar; 15(3):173-82. PubMed ID: 18157145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human mesenchymal stem cells lack tumor tropism but enhance the antitumor activity of oncolytic adenoviruses in orthotopic lung and breast tumors.
    Hakkarainen T; Särkioja M; Lehenkari P; Miettinen S; Ylikomi T; Suuronen R; Desmond RA; Kanerva A; Hemminki A
    Hum Gene Ther; 2007 Jul; 18(7):627-41. PubMed ID: 17604566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D3-inducible mesenchymal stem cell-based delivery of conditionally replicating adenoviruses effectively targets renal cell carcinoma and inhibits tumor growth.
    Hsiao WC; Sung SY; Liao CH; Wu HC; Hsieh CL
    Mol Pharm; 2012 May; 9(5):1396-408. PubMed ID: 22480282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of metastatic neuroblastoma with systemic oncolytic virotherapy delivered by autologous mesenchymal stem cells: an exploratory study.
    García-Castro J; Alemany R; Cascalló M; Martínez-Quintanilla J; Arriero Mdel M; Lassaletta A; Madero L; Ramírez M
    Cancer Gene Ther; 2010 Jul; 17(7):476-83. PubMed ID: 20168350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxic mesenchymal stem cells engraft and ameliorate limb ischaemia in allogeneic recipients.
    Huang WH; Chen HL; Huang PH; Yew TL; Lin MW; Lin SJ; Hung SC
    Cardiovasc Res; 2014 Feb; 101(2):266-76. PubMed ID: 24220639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A specific subpopulation of mesenchymal stromal cell carriers overrides melanoma resistance to an oncolytic adenovirus.
    Bolontrade MF; Sganga L; Piaggio E; Viale DL; Sorrentino MA; Robinson A; Sevlever G; García MG; Mazzolini G; Podhajcer OL
    Stem Cells Dev; 2012 Sep; 21(14):2689-702. PubMed ID: 22462538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cell carriers enhance antitumor efficacy of oncolytic adenoviruses in an immunocompetent mouse model.
    Rincón E; Cejalvo T; Kanojia D; Alfranca A; Rodríguez-Milla MÁ; Gil Hoyos RA; Han Y; Zhang L; Alemany R; Lesniak MS; García-Castro J
    Oncotarget; 2017 Jul; 8(28):45415-45431. PubMed ID: 28525366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL.
    Kazimirsky G; Jiang W; Slavin S; Ziv-Av A; Brodie C
    Stem Cell Res Ther; 2016 Oct; 7(1):149. PubMed ID: 27724977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic delivery of HER2-retargeted oncolytic-HSV by mesenchymal stromal cells protects from lung and brain metastases.
    Leoni V; Gatta V; Palladini A; Nicoletti G; Ranieri D; Dall'Ora M; Grosso V; Rossi M; Alviano F; Bonsi L; Nanni P; Lollini PL; Campadelli-Fiume G
    Oncotarget; 2015 Oct; 6(33):34774-87. PubMed ID: 26430966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of functional mesenchymal stem cells from rabbit embryonic stem cells by exposure to severe hypoxic conditions.
    Teramura T; Onodera Y; Takehara T; Frampton J; Matsuoka T; Ito S; Nakagawa K; Miki Y; Hosoi Y; Hamanishi C; Fukuda K
    Cell Transplant; 2013; 22(2):309-29. PubMed ID: 22943955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
    Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
    Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental therapy for lung cancer: umbilical cord-derived mesenchymal stem cell-mediated interleukin-24 delivery.
    Zhang X; Zhang L; Xu W; Qian H; Ye S; Zhu W; Cao H; Yan Y; Li W; Wang M; Wang W; Zhang R
    Curr Cancer Drug Targets; 2013 Jan; 13(1):92-102. PubMed ID: 23170786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension.
    Zhang Y; Liao S; Yang M; Liang X; Poon MW; Wong CY; Wang J; Zhou Z; Cheong SK; Lee CN; Tse HF; Lian Q
    Cell Transplant; 2012; 21(10):2225-39. PubMed ID: 22776744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of TGF-β/Smad signaling by BAMBI blocks differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and abolishes their protumor effects.
    Shangguan L; Ti X; Krause U; Hai B; Zhao Y; Yang Z; Liu F
    Stem Cells; 2012 Dec; 30(12):2810-9. PubMed ID: 23034983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma.
    Ahmed AU; Tyler MA; Thaci B; Alexiades NG; Han Y; Ulasov IV; Lesniak MS
    Mol Pharm; 2011 Oct; 8(5):1559-72. PubMed ID: 21718006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of GFP-Bcl-2-engineered mesenchymal stem cells towards a nucleus pulposus-like phenotype under hypoxia in vitro.
    Fang Z; Yang Q; Luo W; Li GH; Xiao J; Li F; Xiong W
    Biochem Biophys Res Commun; 2013 Mar; 432(3):444-50. PubMed ID: 23416353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cells overexpressing C-X-C chemokine receptor type 4 improve early liver regeneration of small-for-size liver grafts.
    Du Z; Wei C; Yan J; Han B; Zhang M; Peng C; Liu Y
    Liver Transpl; 2013 Feb; 19(2):215-25. PubMed ID: 23193024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deferoxamine preconditioning potentiates mesenchymal stem cell homing in vitro and in streptozotocin-diabetic rats.
    Najafi R; Sharifi AM
    Expert Opin Biol Ther; 2013 Jul; 13(7):959-72. PubMed ID: 23536977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.